Science and Technology Education Department of the National Health Commission, Working Guidelines for Clinical Research on Somatic Cells (Draft for Comments)
国家卫健委科技教育司关于体细胞临床研究工作指引 (征求意见稿)
June 19, 2023 | BY
Susan MokThe objective of clinical research on somatic cells is not registration of a pharmaceutical
Issued: May 9, 2023
Applicability: The phrase "clinical research on somatic cells" means clinical research using human mature/functionally differentiated autologous or allogeneic cells that have been manipulated in vitro and which are then returned to (or implanted into) the human body as an investigational intervention for disease treatment. These Guidelines shall apply to clinical research on somatic cells that is initiated by researchers at medical institutions and the objective of which is not registration of a pharmaceutical (Section One).
Main contents: Unlike clinical trials of pharmaceuticals, the initial purpose of clinical research on somatic cells is not their marketing, but rather an early clinical exploration conducted based on its previous research base and used to answer certain scientific questions or to prove certain scientific hypotheses.
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now